S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
66,000% upside on tiny biotech? (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
66,000% upside on tiny biotech? (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Guess What The Fed Is Doing To Your Money Now? (Ad)
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
66,000% upside on tiny biotech? (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
66,000% upside on tiny biotech? (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Guess What The Fed Is Doing To Your Money Now? (Ad)
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
66,000% upside on tiny biotech? (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
66,000% upside on tiny biotech? (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Guess What The Fed Is Doing To Your Money Now? (Ad)
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
66,000% upside on tiny biotech? (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
66,000% upside on tiny biotech? (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Guess What The Fed Is Doing To Your Money Now? (Ad)
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
NASDAQ:IONM

Assure (IONM) Price Target & Analyst Ratings

$0.22
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$0.21
$0.24
50-Day Range
$0.22
$0.85
52-Week Range
$0.20
$14.80
Volume
88,470 shs
Average Volume
398,631 shs
Market Capitalization
$1.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.33

Assure Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 1 Analyst Ratings

Consensus Analyst Price Target

$25.33
11,415.15% Upside
High Prediction$60.00
Average Prediction$25.33
Low Prediction$4.00
TypeCurrent
9/30/22 to 9/30/23
1 Month Ago
8/31/22 to 8/31/23
3 Months Ago
7/2/22 to 7/2/23
1 Year Ago
9/30/21 to 9/30/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$25.33$25.33$25.33$115.00
Predicted Upside11,415.15% Upside566.49% Upside566.49% Upside145.73% Upside
Get Assure Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for IONM and its competitors with MarketBeat's FREE daily newsletter.


IONM Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

IONM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Assure Stock vs. The Competition

TypeAssureMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.66
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside11,415.15% Upside869.97% Upside698.20% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/23/2023Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$8.00 ➝ $4.00+314.93%
4/12/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$60.00 ➝ $12.00+284.61%
11/28/2022Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Henry
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Target$110.00 ➝ $60.00+650.00%
(Data available from 9/30/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












IONM Price Target - Frequently Asked Questions

What is Assure's consensus rating and price target?

According to the issued ratings of 1 analysts in the last year, the consensus rating for Assure stock is Buy based on the current 1 buy rating for IONM. The average twelve-month price prediction for Assure is $25.33 with a high price target of $60.00 and a low price target of $4.00. Learn more on IONM's analyst rating history.

Do Wall Street analysts like Assure more than its competitors?

Analysts like Assure more than other Medical companies. The consensus rating for Assure is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how IONM compares to other companies.

Does Assure's stock price have much upside?

According to analysts, Assure's stock has a predicted upside of 566.49% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:IONM) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -